Oragenics, Inc.
OGEN
$0.59
$0.035.45%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 2.39M | 3.39M | 3.34M | 3.79M | 4.11M |
| Gross Profit | -2.39M | -3.39M | -3.34M | -3.79M | -4.11M |
| SG&A Expenses | 6.97M | 6.83M | 6.20M | 6.33M | 6.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.36M | 10.22M | 9.53M | 10.12M | 10.56M |
| Operating Income | -9.36M | -10.22M | -9.53M | -10.12M | -10.56M |
| Income Before Tax | -9.98M | -10.90M | -10.30M | -10.33M | -10.57M |
| Income Tax Expenses | -136.90K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.84 | -10.90 | -10.30 | -10.33 | -10.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.84M | -10.90M | -10.30M | -10.33M | -10.57M |
| EBIT | -9.36M | -10.22M | -9.53M | -10.12M | -10.56M |
| EBITDA | -- | -3.35M | -5.78M | -8.08M | -10.53M |
| EPS Basic | -9.26 | -13.72 | -23.08 | -35.24 | -52.62 |
| Normalized Basic EPS | -5.81 | -8.58 | -14.42 | -22.03 | -32.89 |
| EPS Diluted | -9.26 | -13.72 | -23.08 | -35.24 | -52.62 |
| Normalized Diluted EPS | -5.81 | -8.58 | -14.42 | -22.03 | -32.89 |
| Average Basic Shares Outstanding | 7.13M | 3.57M | 2.23M | 1.65M | 1.15M |
| Average Diluted Shares Outstanding | 7.13M | 3.57M | 2.23M | 1.65M | 1.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |